Ultrasound vs Veinviewer in Patients With Difficulty IV Access

Sponsor
University of Maryland, Baltimore (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT02618252
Collaborator
(none)
216
1
2
88
2.5

Study Details

Study Description

Brief Summary

Patients with difficulty intravenous access frequently have delay of care in emergency departments because Emergency Department (ED) personnel could not establish intravenous (IV) access for diagnostic blood test or treatment. The ultrasound machine or near-infrared devices have been used to improve this situation but no study has ever compared which machine is more efficient. This study is designed to investigate whether the ultrasound or Vein Viewer, which is a near-infrared device, is more efficient.

Condition or Disease Intervention/Treatment Phase
  • Device: Zonare
  • Device: Veinviewer
N/A

Detailed Description

Intravenous (IV) access is important for patient care in emergency medicine as an estimate of 78% of ED patients would require more than 3 ED resources such as blood tests, medication, contrast, fluid. Care for patients with difficult intravenous access (DIVA) could be significantly delayed as it may take up to 120 minutes to establish IV access in patients with severe DIVA. Many solutions for DIVA had also been established to avoid central venous catheter insertion, including using ultrasound or near-infrared imaging systems for peripheral IV insertion.

Using ultrasound in the ED has been shown to decrease the rate of central venous catheters (CVC) insertion. However, the results from ultrasound-guided peripheral IV insertion (USGPIV) have been mixed. Among patients with DIVA, Costantino reported USGPIV required less time to successful first cannulation and fewer punctures comparing to traditional approach of landmark and palpation. However, other studies showed that USGPIV did not improve successful first attempts comparing to traditional IV insertion, and may have taken same or even longer time to successfully establish IV. USGPIV success rate requires more training for nurses and ED technicians as it is operator - dependent.

Patients have difficulty with IV access because their veins' clinical accessibility is low, for example, they are less visible or less palpable. The near-infrared imaging devices, such as Christie Digital's VeinViewer, improve this situation by using infra-red lights to make veins visible to the eyes.

Compared with routine IV insertion, near-Infra red imaging devices have been shown to increase first successful attempts and in less time in children with DIVA and improved visualization of peripheral veins. However, it did not show higher rate of successful attempts nor faster time in non-selected adults.

The efficacy of these near-infrared devices has not been established among adult patients with DIVA.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
216 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Preventing Delay of Care in Patient With Difficult IV Access: A Randomized Trial of ED Intervention
Actual Study Start Date :
Aug 1, 2016
Anticipated Primary Completion Date :
Dec 1, 2023
Anticipated Study Completion Date :
Dec 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Zonare

108 patients are randomized to receive the intervention of using ultrasound machine (Zonare ZS3 machine) for IV cannulation. These patients will first undergo IV cannulation with assistance of the ultrasound machine.

Device: Zonare
Patients with difficulty IV access are randomized to receive either intervention with ultrasound machine (Zonare ZS3 machine) or the Veinviewer Flex machine.

Experimental: Veinviewer

108 Patients are randomized to receive the Intervention of using the Veinviewer Flex machine for IV cannulation. These patients will first undergo IV cannulation with assistance of the Veinviewer Flex machine.

Device: Veinviewer
Patients with difficulty IV access are randomized to receive either intervention with ultrasound machine (Zonare ZS3 machine) or the Veinviewer Flex machine.

Outcome Measures

Primary Outcome Measures

  1. Operator's time [up to 40 minutes]

    time from equipment-in-room to successful aspiration of 3ml of blood

Secondary Outcome Measures

  1. Number of first successful attempts [40 minutes]

    operators have up to 40 minutes or 3 attempts.

  2. Number of failures [40 minutes]

    operators have up to 40 minutes or 3 attempts prior to patients crossing over or requiring a rescue modality

  3. IV size [40 minutes]

    operators have up to 40 minutes or 3 attempts to establish IV from 18 to 24 gauge

  4. Patient satisfaction [up to 40 minutes]

    after completion of IV cannulation

  5. Patient's perception of pain [up to 40 minutes]

    after completion of IV cannulation

  6. ED length of stay [24 hours]

    Length of stay for discharged patients.

  7. hospital length of stay for admitted patient [30 days]

    Length of stay for admitted patients

  8. Cannulation time [40 minutes]

    time from applying tourniquet to successful aspiration of 3ml of blood.

  9. Number of failure to cannulate [40 minutes]

    operators have up to 40 minutes or 3 attempts.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who fail inspections for visible or palpable veins or

  • Patients who request Ultrasound guided peripheral IV (USGPIV)

  • patients who are oriented to self (correct last name, first name), place (correct name of hospital), time (correct day of week or month of year) and person (correct name of current president)

Exclusion Criteria:
  • Patients < 18 years of age

  • Patients with hemodynamically instability requiring rapid central access.

  • Patients with impaired cognition and not able to consent, these patients are :

  • Clinically intoxicated patients, as defined by primary team.

  • Patients who family reported as "confused", "confusion", "altered mental status."

  • Patients who is not oriented x 4 as above

  • Patients who do not speak English.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Maryland Medical Center Baltimore Maryland United States 21201

Sponsors and Collaborators

  • University of Maryland, Baltimore

Investigators

  • Principal Investigator: Quincy Tran, MD, PhD, University of Maryland

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Quincy Tran, Assosciate Professor, University of Maryland, Baltimore
ClinicalTrials.gov Identifier:
NCT02618252
Other Study ID Numbers:
  • HP-00065438
First Posted:
Dec 1, 2015
Last Update Posted:
Jan 27, 2022
Last Verified:
Jan 1, 2022
Keywords provided by Quincy Tran, Assosciate Professor, University of Maryland, Baltimore

Study Results

No Results Posted as of Jan 27, 2022